Navigation Links
Epilepsy Drug Helps Diabetic Nerve Damage

Over the weekend, researchers from Eastern Virginia Medical School presented their study that shows the anti-epileptic drug topiramate improves diabetic neuropathy, or nerve damage.Topiramate (Topamax) has long been used to treat epilepsy, and recent research shows it can also promote significant weight loss. In a small study of people with type 2 diabetes, the drug showed evidence of improving symptoms and markers of neuropathy.// Neuropathy is damage to the nerves that produces pain, impaired heat and pain perception, and disordered skin blood flow that predisposes a person to skin ulcers. Those ulcers can often be cause for amputation.
Aaron Vinik, M.D., from Eastern Virginia Medical School in Norfolk, presented the results of a study in which he and colleagues gave a daily dose of topiramate (no more than 100 milligrams/day) to 11 participants with neuropathy. At the end of the eight-week study, markers of neuropathy -- dendrite length, intraepidermal nerve fiber density and peroneal nerve amplitude -- all increased in the patients. What that means, explains Dr. Vinik, is that the nerves were healing. Patients also experienced increased sensitivity to touch and a significant reduction in pain.

There are other benefits of the drug for type 2 diabetes patients as well, says Dr. Vinik. His study shows the drug reduced triglycerides, decreased hemoglobin A1C levels (a measure of long-term blood sugar control), lowered LDL or "bad" cholesterol, and lowered total cholesterol. Since about 65 percent of people with diabetes will die of heart disease, these are significant benefits for patients.


'"/>




Page: 1

Related medicine news :

1. General Anesthesia Safe For Children On Ketogenic Diet Suffering From Epilepsy
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Epilepsy can be predicted
4. Epilepsy Drugs Can Enhance Risk of Birth Defects
5. Epilepsy Drug May Relieve Chronic Headaches
6. More Complications Seen In Women With Epilepsy
7. Epilepsy Drugs Found To Lead To Bone Loss
8. Another Use For Epilepsy Drugs
9. Epilepsy Patients Could Benefit From Pacemakers
10. Early Surgery For Treatment Of Epilepsy Questioned
11. Epilepsy Drug Valproate and Lamotrigine Linked To Malformed Fetus
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2017)... Angeles, California (PRWEB) , ... May 26, 2017 , ... ... senior citizens who visit a doctor for colds or respiratory issues that are not ... that excessive time pressure on doctors may be largely responsible for the problem both ...
(Date:5/27/2017)... ... , ... Most us are familiar with the sound of occasional popping joints ... Initiative shows that certain people who experience consistent joint popping, grating and grinding ... the opportunity to treat patients before the problem becomes pronounced, potentially hedging off more ...
(Date:5/26/2017)... ... May 26, 2017 , ... The ... educational seminar to focus on current legislative activity and the latest regulatory concerns ... 1 p.m. Sunday, Sept. 10, and will continue through Monday, Sept. 11, at ...
(Date:5/26/2017)... ... 2017 , ... Boar’s Head Brand®, one of the nation’s ... entertaining that are sure to satisfy your guests’ flavor cravings, while adding delicious ... featured in these refreshingly balanced recipes are packed with flavor, creating the perfect ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Yisrayl Hawkins, ... new publication this week that is focusing on the Peace Agreements being discussed by ... Middle East sprint in a race to try to speed up peace talks in ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... May 22, 2017  As the specialty pharmacy ... continue to make the revolutionary shift from volume-based ... for ensuring positive patient outcomes and shaping the ... shifting focus away from clinical trials and toward ... long-term specialty drug therapy utilization in precise patient ...
(Date:5/18/2017)... 2017  Bayer announced today that the latest research ... at the 53 rd Annual Meeting of the ... 2-6 in Chicago . ... colorectal, liver and thyroid cancers, as well as lymphomas, ... CHRONOS-1 trial of copanlisib in patients with relapsed or ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
Breaking Medicine Technology: